Moxetumomab pasudotox and Retrovir Infusion
Determining the interaction of Moxetumomab pasudotox and Retrovir Infusion and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: zidovudine
Brand name: Retrovir
Synonyms: Zidovudine (oral/injection), Zidovudine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Retrovir Intravenous
- Moxetumomab pasudotox-Retrovir oral/injection
- Moxetumomab pasudotox-Revatio
- Moxetumomab pasudotox-Revatio Injection
- Moxetumomab pasudotox-Revatio Intravenous
- Moxetumomab pasudotox-Revefenacin
- Retrovir Infusion-Moxetumomab Pasudotox-tdfk
- Retrovir Infusion-Moxetumomab pasudotox-tdfk Intravenous
- Retrovir Infusion-Moxifloxacin
- Retrovir Infusion-Moxifloxacin (Systemic)
- Retrovir Infusion-Moxifloxacin Hydrochloride
- Retrovir Infusion-Moxifloxacin Injection